Cite
Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia.
MLA
Choi, Ho Jung, et al. “Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia.” Journal of Pediatric Hematology/Oncology, vol. 43, no. 2, Mar. 2021, pp. e280–83. EBSCOhost, https://doi.org/10.1097/MPH.0000000000001789.
APA
Choi, H. J., Choi, J. Y., Kim, B. K., An, H. Y., Hong, K. T., Shin, H. Y., & Kang, H. J. (2021). Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology, 43(2), e280–e283. https://doi.org/10.1097/MPH.0000000000001789
Chicago
Choi, Ho Jung, Jung Yoon Choi, Bo Kyung Kim, Hong Yul An, Kyung Taek Hong, Hee Young Shin, and Hyoung Jin Kang. 2021. “Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia.” Journal of Pediatric Hematology/Oncology 43 (2): e280–83. doi:10.1097/MPH.0000000000001789.